Published February 16, 2018
| Version v1
Journal article
Open
CARDIAC DOSES IN LEFT SIDED BREAST CANCER RADIOTHERAPY TREATED WITH BI-TANGENTIAL CONVENTIONAL BEAMS: DATA FROM REGIONAL CANCER CENTRE (RCC) IN NORTH EAST INDIA
Creators
- 1. Department of Radiation Oncology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya
- 2. Department of Radiation Oncology & Medical Physics, Dr. B. Borooah Cancer Institute, Guwahati, Assam
- 3. Department of Radiation Oncology, Cancer Hospital, Gauhati Medical College, Guwahati, Assam
Description
Radiation induced cardiac adverse events are significant reasons for morbidity and mortality in long term survivors of breast cancer. We are reporting the cardiac doses in patients receiving radiotherapy for breast cancer at our centre treated with computed tomography (CT) simulation based bi-tangential conventional beams plans. The main purpose of this study was to determine radiotherapy doses received by heart and correlation of data with published literature. The values obtained will be used to improve cardiac doses at our centre.
Files
296.pdf
Files
(336.8 kB)
Name | Size | Download all |
---|---|---|
md5:456f90ea75c2b5eecece8a7b69d87e37
|
336.8 kB | Preview Download |
Additional details
References
- 1. Schubert LK, Gondi V, Sengbusch E, et al. Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol 2011; 100:241-6. 2. Jagsi R, Moran J, Marsh R, Masi K, Griffith KA, Pierce LJ. Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer. Int J Radiat Oncol Biol Phys 2010; 78:1594-603. 3. Lohr F, El-Haddad M, Dobler B, et al. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys 2009; 74:73-80. 4. Ares C, Khan S, MacArtain AM, et al. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? Int J Radiat Oncol Biol Phys 2010; 76:685-97. 5. Gulybán A, Kovacs P, Sebestyen Z, et al. Multisegmented tangential breast fields: a rational way to treat breast cancer. Strahlenther Onkol 2008; 184:262-9. 6. Aznar MC, Korreman S-S, Pedersen AN, Persson GF, Josipovic M, Specht L. Evaluation of dose to cardiac structures during breast irradiation. Br J Radiol 2011; 84:743-6. 7. Taylor CW, Povall JM, McGale P, et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys 2008; 72:501-7. 8. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. New Engl J Med (2002) 347(16):1233–41.doi:10.1056/ NEJMoa022152. 9. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365:1687–717. 10. McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson N, Bennet AM, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol (2011) 100(2):167–75. doi:10.1016/j.radonc.2011.06.016. 11. Carr ZA, Land CE, Kleinerman RA, et al. Coronary heart disease after radiotherapy for peptic ulcer disease. Int J Radiat Oncol Biol Phys 2005; 61:842-50. 12. Shimizu Y, Kodama K, Nishi N, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ 2010; 340:b5349. 13. Azizova TV, Muirhead CR, Druzhinina MB, et al. Cardiovascular diseases in the cohort of workers first employed at Mayak PA in 1948–1958. Radiat Res 2010; 174:155-68. 14. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N EnglJMed (2013) 368(11):987–98.doi:10.1056/NEJMoa1209825. 15. Robert E. Beck, Leonard Kim, Ning J.Yue, Bruce G. Haffty, et al. Treatment techniques to reduce cardiac irradiation for breast cancer patients treated with breast-conserving surgery and radiation therapy: a review. November 2014 | Volume 4 | Article 327, doi: 10.3389/fonc.2014.00327. 16. RTOG; https://www.rtog.org/CoreLab/ContouringAtlases/BreastCancerAtlas.aspx 17. Mary Feng, M.D, Jean M. Moran, Todd Koelling, Aamer Chughtai, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011 January 1; 79(1): 10–18. doi:10.1016/j.ijrobp.2009.10.058. 18. Tomas Rodrigo Merino Lara, Emmanuelle Fleury, Shahram Mashouf, Joelle Helou, et al. Measurement of mean cardiac dose for various breast irradiation techniques and corresponding risk of major cardiovascular event. October 2014 | Volume 4 | Article 284 doi: 10.3389/fonc.2014.00284. 19. Swanson T, Grills IS , Ye H , Entwistle A , Teahan M , Letts N, et al . Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early- stage or locally advanced breast cancer. Am J Clin Oncol (2013) 36(1):24–30. doi:10.1097/COC.0b013e31823fe481. 20. Joanne S Haviland, J Roger Owen, John A Dewar, Rajiv K Agrawal et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials; Lancet Oncol 2013; 14: 1086–94.